LMVFX | VIVAX | LMVFX / VIVAX | |
Total Expense Ratio | 1.14 | 0.17 | 671% |
Annual Report Gross Expense Ratio | 1.17 | 0.17 | 688% |
Fund Existence | 25 years | 33 years | - |
Gain YTD | 7.705 | 9.738 | 79% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.92B | 208B | 2% |
Annual Yield % from dividends | 0.37 | 1.97 | 19% |
Returns for 1 year | -2.75 | 4.63 | -59% |
Returns for 3 years | 25.82 | 42.99 | 60% |
Returns for 5 years | 40.70 | 71.78 | 57% |
Returns for 10 years | 83.74 | 129.45 | 65% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ARYVX | 13.87 | 0.10 | +0.73% |
American Century Global Real Estate Inv | |||
DESUX | 25.89 | 0.16 | +0.62% |
DWS ESG Core Equity R6 | |||
TWQZX | 16.61 | 0.07 | +0.42% |
Transamerica Large Cap Value I2 | |||
OFSFX | 22.10 | -0.01 | -0.05% |
Olstein Strategic Opportunities Adviser | |||
PASTX | 62.19 | -0.08 | -0.13% |
T. Rowe Price Science & Tech Adv |